Pharmaceutical Accountability Foundation

We are working in the public interest to hold pharmaceutical companies accountable. Your signature can make a difference.

Show your support for the Pharmaceutical Accountability Foundation

The Pharmaceutical Accountability Foundation works in the public interest to make overpriced medicines more affordable holding pharmaceutical companies accountable by taking legal actions.

Your signature on the Statement of Support below helps us demonstrate that we act in the public interest. 

We are a small non-profit organisation that addresses pharmaceutial industry. Help us continue our work by making a donation. Stay informed with our newsletter.

Statement of Support

In my profession I see the consequences of unreasonable prices for medicines and medical technologies.

-and/or-

I see that there is less than optimal care in society when a pharmaceutical company charges an unreasonably high price for a drug or medical technology.

-and/or-

My patients experience negative consequences when an existing medicine is made (much) more expensive, sometimes without adjustments. E.g. upon registration as an orphan drug or drug hijacking.

-and/or-

I have my own reason, which I would like to specify as a comment with my signature.

I hereby express my sympathy and want to contribute to achieving the goal of the foundation, which is to make medicines and medical technologies affordable and accessible to everyone.

Learn more about the Foundation’s mission.

See the data processing and conditions for signing.

!

Current Supporters

Organisations

client-image
client-image
client-image
client-image
client-image

Interested in your organisation being added here? Contact us at info@farmaterverantwoording.nl. 

Committee of Recommendation

Our Committee of Recommendation exists of inspiring people and (academic) experts affiliated with the field of (access to) medicines and healthcare.

Em. Prof. Dr. André Knottnerus

Physician epidemiologist, former chair of the Health Council, and emeritus professor of family medicine at Maastricht University. He publishes regularly on the need to treat essential medicines and vaccines as global public goods.

Prisca Zwanikken, MD, M.Sc.CH, PhD

Senior public health expert, involved in capacity building of training and educational institutions in low- and middle-income countries. A long-time member of HAI, she is also involved in teaching Rational Drug Use

Prof. Gerrit van der Wal, MD, PhD

Advisor and supervisor health care, former GP, emeritus professor of public health and former Inspector-General/CMO Netherlands.

Prof. Dr. Pim van Gool

Professor of Neurology at Public and Occupational Health Amsterdam UMC and former chair of the Health Council of the Netherlands.

Em. Prof. dr. F.M. Haaijer-Ruskamp

Emertitus Professor Drug Use UMCG. Expertise on rational prescribing and drug use, with attention to both individual (e.g., decisions) and macro-level influences, such as policy, price, and pharma industry.

Gilles de Wildt

Associate Clinical Professor Global Health at University of Birmingham (UK) and General Practitioner (Primary care Physician).

Chris Oomen

Entrepeneur, pharmacist and former chair of the board of DSW health insurance organisation.

Godelieve van Heteren, MB, MD

Senior international health, governance and Performance Based Financing consultant. Former member Dutch Parliament (PvdA).

Individuals

Latest Signatures
65 Ini Huijts Netherlands onafhankelijk public health consultant
64 Arnold Daems France oud tandarts
63 Paul Vellekoop Netherlands ambtenaar
62Anonymous Netherlands Bewindvoerder
61 Aad de Groot Netherlands Voorzitter RvB DSW Zorgverzekeraar Ja ik onderteken uit naam van DSW
60 Chris Oomen Netherlands Zelfstandig ondernemer, apotheker, voormalig voorzitter RvB DSW Zorgverzekeraar
59 Iris Wichers Netherlands Huisarts
58 Diederik Aarendonk Netherlands European Forum for Primary Care Competition in Health Care provision leads to more health inequity
57Anonymous Netherlands Apotheker
56 Marielle Bemelmans Netherlands Director People worldwide have the right to health. Pharmaceutical companies have human rights obligations.
55 Pieter van den Hombergh Netherlands EFPC EFPC WG aks for action on AMR
54 Jacob Hamel United Kingdom Public Health Arts & Consultant (tropics) alle mensen hebben recht op best mogelijk toegang tot medicijnen en gezondheidszorg
53 Gilles de Wildt United Kingdom Associate Clinical Professor, Global Health
52 Jan Borg Netherlands Public Health Consultant
51 Jennifer Sellin Netherlands Assistant Professor international human rights law, Faculty of Law, Maastricht University
50 Kees Godschalk Netherlands particulier
49 Trecy Hemedi Netherlands Student at Vrije University
48 Frans M Lindelauf Netherlands oud-ziekenhuisapotheker
47 Paul Jonas Netherlands Arts econometrist Leids Universitair Medisch Centrum Medicijnen zijn een maatschappelijk goed,dat niet in particuliere handen hoort.
46 Prisca Zwanikken Netherlands Public Health Consultant
45 Francisco Rossi Colombia Senior Adviser I see the negative consequences in society because pharmaceutical companies do not act in line with human rights principles, such as the right to health care and access to medicine.
44 Elina Hemminki Finland LSV I see that there is less than optimal care in society when a pharmaceutical company charges an unreasonably high price for a drug or medical technology.
43 Lucas van der Hoeven Netherlands psycholoog / journalist
42 Ewout Kattouw Netherlands Voorzitter stichtjng PILL
41 Marta Medina Denmark Public Health Consultant
40 Kirsten Myhr Norway MScPharm, MPH Because high prices is a barrier to access
39 Krisantha Weerasuriya Sri Lanka Professor Emeritus of Pharmacology, University of Colombo Those of us in LMICs have been campaigning for this from 1990s. Welcome ! I sign as an individual.
38Anonymous Netherlands UHD
37 Staffan Svensson Sweden GP, Clinical Pharmacologist, Hjällbo Vårdcentral Närhälsan
36 Mohga Kamal-Yanni United Kingdom Freelance
35 Patrick Durisch Switzerland Health Policy Expert, Public Eye I see the negative consequences in society because pharmaceutical companies do not act in line with human rights principles, such as the right to health care and access to medicine.
34 Chinu Srinivasan India Mngmnt, Low Cost Standard Therapeutics It is important work you are doing
33 Adriane Fugh-Berman United States Director, PharmedOut
32 Ellen Shaffer United States Co-Director, Center for Policy Analysis on Trade and Health (CPATH)
31 Arta Denina Latvia Doctoer
30 Eleni Alevritou Greece Vice president of Consumer Association the Quality of Life-EKPIZO
29 Monique De Koning Netherlands Publlic Health officer Oneigenlijk gebruik van monopolies leidt tot hoge zorgkosten en schaadt de toegankelijkheid van zorg in Nederland en wereldwijd. Gebruik makend van kennis uit publiek gefinancierde wetenschap, vindt extreme verrijking plaats. Ook het klimaat wordt geschaad in dit ongelijkheid versterkende systeem.
28 Dorothea Hege-Voelksen Switzerland Indecent Consultant
27 Joel Lexchin Canada Professor Emeritus, York University Access to affordable medicines is a human right.
26 Irene Schipper Netherlands Onderzoeker SOMO Misbruik van monopolies als het om medidijnen gaat moet niet door overheden gefaciliteerd worden
25Anonymous Kenya Supply Chain Specialist, Independent consultant I work in the humanitarian sector and seeing inflated cost of pharmaceuticals rendering families bankrupt and living without hope is painful
24 Lisa Konickx Netherlands Apotheker Steunt bij deze
23Anonymous Netherlands Docent, HU -
22 Evianne van der Kruk Netherlands Openbaar apotheker bij apotheek Stelle en docent farmacotherapie aan UU Medicijnen zouden voor iedereen beschikbaar en betaalbaar moeten zijn.
21 Adriaan Mutsaers Netherlands Zzp -
20 Eric van der Borg Netherlands ApotheekVrij Eerlijk duurt het langst!
19 Johan van Luijn Netherlands Apotheker niet-praktiserend hoge prijzen ondermijnen de solidariteit van ons zorgstelsel en maakt dat wereldwijd vele geen toegang kunnen krijgen tot goede zorg. Farmaceutische bedrijven maken oneigenlijk gebruik van hun monopolie posities en zetten daarmee de betaalbaarheid van de zorg onder druk
18 Hans van Commenee Netherlands openbaar apotheker/Leeuwen Apotheek Een medicijn tegen asociaal gedrag?
17Anonymous Netherlands apotheker Hopelijk heeft het effect!
16 Gabriel Montalvo Netherlands UvA There was a presentation at the Uva where I attend school at.
15 Jan Pieter de Jong Netherlands Apotheker (Spangen Rdam) Doorgaan!
14 Guus Eskens Netherlands Bestuurslid Healthnet TPO Doorzetten ! Belangrijke campagne !
13Anonymous Netherlands Ziekenhuisapotheker Eindelijk, go get them!
12 Herma Lobik Netherlands Apotheek van der Laan veel succes!
11Anonymous Netherlands Apotheker np
10 Tessa Jager Switzerland IHEID MA in International Law, former GCCP coordinator Good luck!
9 Richard van Slobbe Netherlands Apotheker/consultant Put the pressure on!
8Anonymous Finland Secretary of the Board, PAF Sign the statement of support!
7 Wilbert Bannenberg Netherlands public health consultant prima aktie!
6 Rosalind Turkie France RESEARCHER access to meds is a human rights issue!
5Anonymous Netherlands Medical writer, PPG Medicijnen moeten toegankelijk en betaalbaar zijn voor iedereen. Geen misbruik van machtspositie!
4 Kaitlin Mara Switzerland Researcher/Writer toegang tot medicijnen voor iedereen!

Individual Supporters

Latest Signatures
65 Ini Huijts Netherlands onafhankelijk public health consultant
64 Arnold Daems France oud tandarts
63 Paul Vellekoop Netherlands ambtenaar
62Anonymous Netherlands Bewindvoerder
61 Aad de Groot Netherlands Voorzitter RvB DSW Zorgverzekeraar Ja ik onderteken uit naam van DSW
60 Chris Oomen Netherlands Zelfstandig ondernemer, apotheker, voormalig voorzitter RvB DSW Zorgverzekeraar
59 Iris Wichers Netherlands Huisarts
58 Diederik Aarendonk Netherlands European Forum for Primary Care Competition in Health Care provision leads to more health inequity
57Anonymous Netherlands Apotheker
56 Marielle Bemelmans Netherlands Director People worldwide have the right to health. Pharmaceutical companies have human rights obligations.
55 Pieter van den Hombergh Netherlands EFPC EFPC WG aks for action on AMR
54 Jacob Hamel United Kingdom Public Health Arts & Consultant (tropics) alle mensen hebben recht op best mogelijk toegang tot medicijnen en gezondheidszorg
53 Gilles de Wildt United Kingdom Associate Clinical Professor, Global Health
52 Jan Borg Netherlands Public Health Consultant
51 Jennifer Sellin Netherlands Assistant Professor international human rights law, Faculty of Law, Maastricht University
50 Kees Godschalk Netherlands particulier
49 Trecy Hemedi Netherlands Student at Vrije University
48 Frans M Lindelauf Netherlands oud-ziekenhuisapotheker
47 Paul Jonas Netherlands Arts econometrist Leids Universitair Medisch Centrum Medicijnen zijn een maatschappelijk goed,dat niet in particuliere handen hoort.
46 Prisca Zwanikken Netherlands Public Health Consultant
45 Francisco Rossi Colombia Senior Adviser I see the negative consequences in society because pharmaceutical companies do not act in line with human rights principles, such as the right to health care and access to medicine.
44 Elina Hemminki Finland LSV I see that there is less than optimal care in society when a pharmaceutical company charges an unreasonably high price for a drug or medical technology.
43 Lucas van der Hoeven Netherlands psycholoog / journalist
42 Ewout Kattouw Netherlands Voorzitter stichtjng PILL
41 Marta Medina Denmark Public Health Consultant
40 Kirsten Myhr Norway MScPharm, MPH Because high prices is a barrier to access
39 Krisantha Weerasuriya Sri Lanka Professor Emeritus of Pharmacology, University of Colombo Those of us in LMICs have been campaigning for this from 1990s. Welcome ! I sign as an individual.
38Anonymous Netherlands UHD
37 Staffan Svensson Sweden GP, Clinical Pharmacologist, Hjällbo Vårdcentral Närhälsan
36 Mohga Kamal-Yanni United Kingdom Freelance
35 Patrick Durisch Switzerland Health Policy Expert, Public Eye I see the negative consequences in society because pharmaceutical companies do not act in line with human rights principles, such as the right to health care and access to medicine.
34 Chinu Srinivasan India Mngmnt, Low Cost Standard Therapeutics It is important work you are doing
33 Adriane Fugh-Berman United States Director, PharmedOut
32 Ellen Shaffer United States Co-Director, Center for Policy Analysis on Trade and Health (CPATH)
31 Arta Denina Latvia Doctoer
30 Eleni Alevritou Greece Vice president of Consumer Association the Quality of Life-EKPIZO
29 Monique De Koning Netherlands Publlic Health officer Oneigenlijk gebruik van monopolies leidt tot hoge zorgkosten en schaadt de toegankelijkheid van zorg in Nederland en wereldwijd. Gebruik makend van kennis uit publiek gefinancierde wetenschap, vindt extreme verrijking plaats. Ook het klimaat wordt geschaad in dit ongelijkheid versterkende systeem.
28 Dorothea Hege-Voelksen Switzerland Indecent Consultant
27 Joel Lexchin Canada Professor Emeritus, York University Access to affordable medicines is a human right.
26 Irene Schipper Netherlands Onderzoeker SOMO Misbruik van monopolies als het om medidijnen gaat moet niet door overheden gefaciliteerd worden
25Anonymous Kenya Supply Chain Specialist, Independent consultant I work in the humanitarian sector and seeing inflated cost of pharmaceuticals rendering families bankrupt and living without hope is painful
24 Lisa Konickx Netherlands Apotheker Steunt bij deze
23Anonymous Netherlands Docent, HU -
22 Evianne van der Kruk Netherlands Openbaar apotheker bij apotheek Stelle en docent farmacotherapie aan UU Medicijnen zouden voor iedereen beschikbaar en betaalbaar moeten zijn.
21 Adriaan Mutsaers Netherlands Zzp -
20 Eric van der Borg Netherlands ApotheekVrij Eerlijk duurt het langst!
19 Johan van Luijn Netherlands Apotheker niet-praktiserend hoge prijzen ondermijnen de solidariteit van ons zorgstelsel en maakt dat wereldwijd vele geen toegang kunnen krijgen tot goede zorg. Farmaceutische bedrijven maken oneigenlijk gebruik van hun monopolie posities en zetten daarmee de betaalbaarheid van de zorg onder druk
18 Hans van Commenee Netherlands openbaar apotheker/Leeuwen Apotheek Een medicijn tegen asociaal gedrag?
17Anonymous Netherlands apotheker Hopelijk heeft het effect!
16 Gabriel Montalvo Netherlands UvA There was a presentation at the Uva where I attend school at.
15 Jan Pieter de Jong Netherlands Apotheker (Spangen Rdam) Doorgaan!
14 Guus Eskens Netherlands Bestuurslid Healthnet TPO Doorzetten ! Belangrijke campagne !
13Anonymous Netherlands Ziekenhuisapotheker Eindelijk, go get them!
12 Herma Lobik Netherlands Apotheek van der Laan veel succes!
11Anonymous Netherlands Apotheker np
10 Tessa Jager Switzerland IHEID MA in International Law, former GCCP coordinator Good luck!
9 Richard van Slobbe Netherlands Apotheker/consultant Put the pressure on!
8Anonymous Finland Secretary of the Board, PAF Sign the statement of support!
7 Wilbert Bannenberg Netherlands public health consultant prima aktie!
6 Rosalind Turkie France RESEARCHER access to meds is a human rights issue!
5Anonymous Netherlands Medical writer, PPG Medicijnen moeten toegankelijk en betaalbaar zijn voor iedereen. Geen misbruik van machtspositie!
4 Kaitlin Mara Switzerland Researcher/Writer toegang tot medicijnen voor iedereen!

Data processing and conditions for signing

Clicking “hide name from public” means signing anonymously. Your name will not be displayed on the website. If necessary, it will only be shown confidentially before a court. Other entered data are visible.

The content of the above statement of support may be amended in the future to reflect the current state of affairs. If you want to be kept informed about this or if you want to change your signature, send an email to projectcoordinator@www.pharmaceuticalaccountability.org

We store your data in a database in accordance with AVG guidelines.